Abstract

Background:

Creatine is an endogenously synthesized nitrogenous compound central to cellular energy homeostasis via the phosphocreatine (PCr)–creatine kinase (CK) shuttle. In humans, creatine supplementation is well-established for enhancing skeletal muscle performance, attenuating age-related sarcopenia, and, more recently, for its neuroprotective and cardioprotective properties. Despite the physiological parallels between humans and dogs — particularly with respect to the shared hallmarks of aging — creatine remains largely unmeasured and unsupplemented in canine nutrition. A critical but underappreciated compounding factor is the near-complete degradation of dietary creatine during commercial pet food manufacturing, creating a functional creatine deficit in the majority of companion dogs fed processed diets.

Objective:

This review synthesizes the available evidence on creatine supplementation in dogs, with a focus on bioavailability, performance outcomes, anti-sarcopenic potential, neuroprotection, cardioprotection, and safety. It further evaluates guanidinoacetic acid (GAA), the direct biosynthetic precursor to creatine, as a stable alternative for dietary delivery, and provides evidence-based practical recommendations for longevity-focused pet owners.

Methods:

A narrative review of peer-reviewed literature was conducted across PubMed, PMC, and Google Scholar, supplemented by data from veterinary clinical studies, comparative gerontology research, and expert commentary published in peer-reviewed veterinary journals. Studies were selected for relevance to canine physiology, aging biology, creatine metabolism, and supplementation outcomes in companion animals and closely related mammalian models.

Results: Oral creatine monohydrate is bioavailable in dogs, producing a greater than 20-fold increase in postprandial plasma creatine concentrations within 30 minutes of supplemented feeding (Banton et al., 2022). A controlled trial in competitive agility dogs demonstrated a statistically significant improvement in repeated sprint performance of approximately 0.5 seconds following 15 days of supplementation at 0.2 g/kg body weight, with a concurrent trend toward reduced blood lactate accumulation (Casini et al., 2016). Commercial pet food manufacturing processes substantially degrade creatine monohydrate, with recovery rates of only 36% following retorting and further losses of up to 63% during storage of extruded diets; GAA demonstrated markedly superior stability, with recovery rates of 79–99% across both manufacturing processes (van der Poel et al., 2019). In an accelerated aging murine model, long-term creatine supplementation reversed cognitive impairment, attenuated hippocampal oxidative stress, and increased brain-specific creatine kinase (CK-BB) activity by 36% and expression by 14.3%, identifying a plausible neuroprotective mechanism directly relevant to Canine Cognitive Dysfunction (Zhu et al., 2025). Myocardial creatine and phosphocreatine depletion has been identified as an early biomarker of cardiac energy failure in canine models of heart failure, preceding measurable ATP decline and suggesting a role for creatine repletion in cardiac support (Ten Hove et al., 1999). Creatine supplementation at appropriate doses did not impair renal function in animal models with pre-existing renal failure (Taes et al., 2003); however, supplementation predictably elevates serum creatinine, creating a significant risk of misdiagnosis of chronic kidney disease in the absence of pre-supplementation baseline values.

Conclusions: The evidence supports creatine supplementation as a multi-target longevity intervention in dogs, with demonstrated or mechanistically plausible benefits across skeletal muscle preservation, cognitive function, and cardiac bioenergetics. The functional creatine deficit induced by commercial pet food processing represents an underappreciated nutritional gap that warrants attention from both clinicians and the pet food industry. GAA is identified as the preferred vehicle for dietary creatine delivery due to its superior manufacturing stability. Supplementation with creatine monohydrate at 50–200 mg/kg body weight per day appears safe in healthy dogs, but establishment of pre-supplementation renal baselines and transparent communication with the attending veterinarian are essential to avoid misinterpretation of expected creatinine elevations. Prospective, randomized controlled trials in senior dogs are urgently needed to establish definitive dosing protocols, long-term safety data, and efficacy endpoints for sarcopenia, cognitive function, and cardiac health.

Creatine Supplementation in Aging Dogs: A Narrative Review of Bioavailability, Efficacy, Safety, and Longevity Applications

Introduction

Creatine, an endogenously produced nitrogenous organic acid pivotal for cellular energy metabolism, has been a cornerstone of human sports nutrition and, increasingly, longevity medicine for decades. Its role in replenishing adenosine triphosphate (ATP) via the phosphocreatine shuttle, building and preserving muscle mass, and its emerging neuroprotective and cardioprotective benefits are well-documented in humans. This executive brief explores the translation of these benefits to the canine world, providing a comprehensive analysis of creatine supplementation for pet owners interested in maximizing their dogs' healthspan and longevity.

In the body, creatine is synthesized primarily in the liver and kidneys from the amino acids arginine and glycine, with the intermediate compound guanidinoacetic acid (GAA) serving as the direct precursor. Approximately 95% of the body's creatine is stored in skeletal muscle, where it is phosphorylated to form phosphocreatine (PCr). During high-intensity exercise or periods of high metabolic demand — including the energy-intensive processes of the aging brain — PCr rapidly donates its phosphate group to ADP to regenerate ATP, providing an immediate energy buffer that is critical for both physical and cognitive performance.

Key Findings

The body of evidence on creatine in dogs is smaller than in humans but is growing rapidly, particularly in the fields of veterinary nutrition, sports medicine, and geroscience. The following represent the most important findings from the current literature.

Creatine is bioavailable in dogs. Studies have confirmed that orally administered creatine monohydrate is readily absorbed by dogs, producing a measurable and substantial increase in plasma creatine concentrations. A 2022 study by Banton et al. found that supplementing a meal with a combination including creatine led to a greater than 20-fold increase in plasma creatine concentration within 30 minutes of feeding in adult dogs [1]. This confirms that the canine gastrointestinal system can absorb supplemental creatine effectively.

Dietary creatine is chronically insufficient in processed-diet-fed dogs. A critical finding from Dobenecker and Braun (2015) is that while unprocessed raw meat diets contain meaningful levels of creatine, heat-processed commercial foods — including extruded kibble and retorted canned food — contain significantly lower to negligible amounts due to the irreversible degradation of creatine into the physiologically inert compound creatinine during high-temperature manufacturing [8]. This creates a functional creatine deficit in the majority of companion dogs.

Guanidinoacetic Acid (GAA) is the superior vehicle for dietary delivery. Van der Poel et al. (2019) demonstrated that creatine monohydrate is highly unstable during food manufacturing, with recovery rates as low as 36% after retorting (canning). GAA, by contrast, survives the manufacturing process with recovery rates of 79–99%, making it the most reliable and commercially viable method for delivering a consistent creatine precursor dose in commercial pet foods [7].

Performance benefits are demonstrable in athletic dogs. Casini et al. (2016) conducted a controlled trial in six competitive Border Collies, supplementing them with 0.2 g/kg body weight of creatine monohydrate for 15 days. The supplemented dogs showed a statistically significant improvement in repeated sprint performance (~0.5 seconds faster in a repeated agility course), with a trend toward reduced blood lactate accumulation between runs [2]. This mirrors the well-established human data on creatine's role in high-intensity, short-duration exercise.

Neuroprotective effects are strongly supported in aging models. Zhu et al. (2025) demonstrated in a D-galactose-induced aging mouse model that long-term creatine supplementation (3% dietary creatine) mitigated cognitive impairment, reduced oxidative stress, and prevented hippocampal structural damage. The mechanism was identified as a 36% increase in the brain-specific isoform of creatine kinase (CK-BB), which is responsible for maintaining energy homeostasis in neurons [4]. Given that Canine Cognitive Dysfunction (CCD) shares pathological hallmarks with Alzheimer's disease in humans, the translational relevance to dogs is high.

Cardiac energy depletion is a feature of canine heart failure. Research has established that creatine and phosphocreatine levels in the myocardium are depleted early in the progression of heart failure in dogs. Loss of creatine has been identified as an early marker of cardiac energy failure, preceding the reduction in ATP itself [5]. This suggests that maintaining myocardial creatine stores could be a meaningful cardioprotective strategy, particularly in breeds predisposed to dilated cardiomyopathy (DCM) or myxomatous mitral valve disease (MMVD).

Data and Statistics

Quantitative data from canine-specific creatine studies are still emerging, but the following key statistics provide a clearer picture of its efficacy and the challenges of dietary delivery.

Expert Opinions and Quotes

The veterinary and animal nutrition community holds a range of views on creatine supplementation, largely reflecting the nascent but accelerating stage of canine-specific research. Opinions span from enthusiastic adoption for specific use cases to cautious skepticism from practitioners who prioritize established evidence.

Researchers Highlighting a Nutritional Gap

Key researchers in the field point out the discrepancy between a dog's physiological need for creatine and the amount supplied in modern processed diets, forming a strong scientific argument for supplementation.

"Although not currently supplemented, or even commonly measured in pet food, creatine has important implications for amino acid and energy metabolism in the dog." — Banton et al., 2022 [1]

"This study showed that GAA is highly stable during production and storage of moist and dry canine foods whilst CrMH is relatively unstable, particularly during storage. The latter makes it difficult to establish a guaranteed Cr content in finished moist retorted and dry extruded foods with CrMH." — van der Poel et al., 2019 [7]

Proponents for Specific Canine Populations

Many practitioners and researchers view creatine as a logical and evidence-supported tool for specific, high-need populations, particularly senior dogs and working athletes.

"Ageing dogs often lose muscle mass (sarcopenia), and creatine might support muscle maintenance or strength, especially when paired with exercise. While direct canine studies are sparse, human research on creatine for elderly muscle health suggests potential parallels." — Advanced Animal Care [3]

Cautious and Skeptical Viewpoints

Some veterinarians urge caution, citing the lack of extensive long-term safety data in dogs and questioning whether the goals of supplementation are appropriate for the average companion animal.

"In general, creatine is probably OK for gym rats and maybe for flyball dogs, but do we really want our canine athletes jacked out like Arnold Schwarzenegger?" — Dr. Matthew Brunke, DVM, quoted in DVM360 [10]

This perspective, while somewhat reductive, underscores a crucial point for the longevity-focused owner: the goal of creatine supplementation in companion animals should be the preservation of functional capacity, cognitive health, and organ integrity — not hypertrophic muscle gain for aesthetic purposes. The framing of creatine as a "bodybuilding supplement" is outdated and misses its most compelling applications in the context of aging biology.

Emerging Trends and Predictions

The landscape of canine nutrition and longevity science is rapidly evolving, and creatine is positioned to play an increasingly prominent role. Based on current research trajectories, several major trends are anticipated.

The primary application of creatine is expected to shift decisively from a niche supplement for elite working dogs to a mainstream tool for promoting healthspan in the broader aging pet population. As veterinary medicine places greater emphasis on quality of life in geriatric patients, interventions targeting sarcopenia and frailty will become standard of care. Creatine, combined with optimized protein intake and structured physical activity, is poised to become a cornerstone of this approach, mirroring the trajectory already seen in human geriatric medicine.

In the pet food industry, we predict a significant increase in the use of GAA as a functional ingredient in premium and therapeutic senior dog foods. Its superior stability during manufacturing makes it the most logical and commercially viable method for delivering a consistent, therapeutic dose of a creatine precursor. This represents a significant market opportunity for innovative pet food companies willing to invest in the geroscience space.

The strong and growing evidence for creatine's role in brain bioenergetics will translate into its use for supporting cognitive function in senior dogs. We anticipate seeing creatine and GAA included in clinical formulations aimed at preventing or managing Canine Cognitive Dysfunction (CCD), capitalizing on the neuroprotective mechanisms identified in aging models [4]. Similarly, given the evidence linking myocardial energy depletion to heart failure in dogs, veterinary-prescribed cardiac support diets and supplements incorporating creatine or GAA are a logical and likely near-term development, particularly for at-risk breeds such as Cavalier King Charles Spaniels, Doberman Pinschers, and Boxers.

Controversial Viewpoints and Debates

Despite its potential, creatine supplementation is not without controversy. The primary debates center on three key areas: safety, dietary delivery, and the interpretation of clinical laboratory data.

Kidney Safety and Creatinine Misinterpretation

The most persistent concern revolves around kidney safety. While studies in humans and other animals — including a study specifically using animals with pre-existing renal failure — have largely debunked the notion that creatine at appropriate doses harms healthy kidneys [6], the concern persists in the veterinary community. A more nuanced and practically critical issue is the potential for diagnostic misinterpretation. Creatine supplementation will reliably elevate serum creatinine levels, as creatinine is the natural, irreversible breakdown product of creatine. In a dog without an established baseline creatinine level, a veterinarian may mistakenly interpret this elevation as evidence of chronic kidney disease (CKD), potentially leading to unnecessary dietary protein restriction or other interventions that could harm the dog. This makes establishing a pre-supplementation baseline and transparently communicating supplementation to the veterinary team an absolute prerequisite.

Raw vs. Processed Diets and the Creatine Deficit

A significant debate exists regarding the natural creatine content in different feeding paradigms. Proponents of raw feeding argue that it provides a natural, bioavailable source of creatine that is irreversibly destroyed during the high-heat extrusion process used to manufacture kibble [8]. The research confirms this: creatine monohydrate is unstable under heat, with substantial losses during pet food manufacturing and further degradation during storage [7]. This has led to the argument that supplementation is primarily necessary to counteract the nutritional deficiencies introduced by modern processed diets. Conversely, even raw diets may not provide consistently therapeutic creatine levels, and the argument for targeted supplementation holds regardless of feeding style.

GAA vs. Creatine Monohydrate for Direct Supplementation

While GAA is clearly superior for inclusion in manufactured pet foods, the debate is less clear-cut for the individual pet owner supplementing directly. Creatine monohydrate is the most extensively studied form in humans, is cost-effective, and is effective when added to food at the time of feeding. GAA, as a precursor, must be converted to creatine in the body via methylation (using SAMe), which introduces an additional metabolic step and a potential concern regarding homocysteine elevation at high doses — a concern that has been raised in human research. For most dogs, direct creatine monohydrate supplementation at the time of feeding remains the most straightforward and evidence-supported approach.

Practical Implications for Pet Owners Interested in Longevity

For the proactive, longevity-focused pet owner, the research points to several clear and actionable implications.

Identify the Right Candidates.

Creatine is not a supplement for every dog, but the population that stands to benefit is broader than commonly assumed. The strongest candidates are senior dogs (generally >7 years) experiencing or at risk of sarcopenia; athletic and working dogs engaged in high-intensity exercise; dogs recovering from injury, surgery, or illness-related muscle wasting; and any dog fed exclusively on heat-processed commercial diets, which constitute the vast majority of companion dogs.

Establish Baselines and Involve Your Veterinarian.

Before initiating supplementation, obtain comprehensive baseline bloodwork, with particular attention to serum creatinine, BUN, and SDMA for kidney function assessment. Inform your veterinarian explicitly that you are beginning creatine supplementation so that future elevations in serum creatinine are correctly attributed to the supplement and not misdiagnosed as renal disease.

Dosing and Form.

The most studied and practical form for direct supplementation is creatine monohydrate. Based on the available canine and cross-species literature, the following dosing framework is a reasonable starting point, though individual veterinary guidance should always be sought:

Creatine monohydrate powder is best administered mixed directly into food at the time of feeding. It is tasteless and odorless, making administration straightforward.

Adopt a Holistic Approach.

Supplementation is a single lever in a broader longevity strategy. To maximize the benefits of creatine, it must be combined with a high-quality, species-appropriate, high-protein diet that provides adequate substrate for muscle protein synthesis; regular, structured physical activity that includes resistance elements (hill work, swimming, leash walking on varied terrain); and proactive veterinary monitoring including regular bloodwork and body composition assessment.

References

[1] Banton, S., et al. (2022). Addition of a combination of creatine, carnitine, and choline to a commercial diet increases postprandial plasma creatine and creatinine concentrations in adult dogs. Journal of Animal Physiology and Animal Nutrition. https://pmc.ncbi.nlm.nih.gov/articles/PMC9731106/

[2] Casini, L., Liponi, G. B., & Gatta, D. (2016). The effect of creatine monohydrate supplementation on blood lactate and performance in agility dogs. Proceedings of the 20th Congress of the European Society of Veterinary and Comparative Nutrition, Berlin. https://www.researchgate.net/publication/308622724

[3] Advanced Animal Care. (2025). Dogs That May Benefit from Creatine. Advanced Animal Care Blog. https://www.advancedanimalcare.shop/post/dogs-that-may-benefit-from-creatine

[4] Zhu, Z., et al. (2025). Long-Term Creatine Supplementation Improves Cognitive and Hippocampal Structural Plasticity Impairments in a D-Gal-Induced Aging Model via Increasing CK-BB Activity in the Brain. Food Science & Nutrition. https://pmc.ncbi.nlm.nih.gov/articles/PMC11733680/

[5] Ten Hove, M., et al. (1999). Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs. Circulation. https://pubmed.ncbi.nlm.nih.gov/10562269/

[6] Taes, Y. E., et al. (2003). Creatine supplementation does not affect kidney function in an animal model with pre-existing renal failure. Nephrology Dialysis Transplantation. https://pubmed.ncbi.nlm.nih.gov/12543878/

[7] van der Poel, A. F. B., Braun, U., Hendriks, W. H., & Bosch, G. (2019). Stability of creatine monohydrate and guanidinoacetic acid during manufacture (retorting and extrusion) and storage of dog foods. Journal of Animal Physiology and Animal Nutrition. https://pmc.ncbi.nlm.nih.gov/articles/PMC6852548/

[8] Dobenecker, B., & Braun, U. (2015). Creatine and creatinine contents in different diet types for dogs — effects of source and processing. Journal of Animal Physiology and Animal Nutrition. https://onlinelibrary.wiley.com/doi/abs/10.1111/jpn.12383

[9] Lee, C. M., et al. (2017). Correlation between serum homocysteine concentration and severity of mitral valve disease in dogs. American Journal of Veterinary Research. https://pubmed.ncbi.nlm.nih.gov/28345991/

[10] Wooten, S. J. (2017). Joint supplements for dogs: The helpful vs. the hype. dvm360. https://www.dvm360.com/view/joint-supplements-dogs-helpful-vs-hype